Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20837828 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions: Drug: Clopidogrel;   Drug: Aspirin
2 Active, not recruiting Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke
Interventions: Drug: Aspirin (80 mg/d) + clopidogrel (75 mg/d);   Drug: Aspirin

Indicates status has not been verified in more than two years